Tune Therapeutics (Series B)
Funding Details
Awarder
Inbox
Date Award
May 19, 2025
Vertical
Epigenome Editing
Funding URL
View Funding Page
Funding Amount
$175,000,000
Company Info
Market
Biotechnology
Location
Durham, North Carolina, USA
Coinvestors
New Enterprise Associates, Yosemite, Regeneron Ventures, Hevolution Foundation
Company Description

Tune Therapeutics is a leading epigenome editing company focused on developing innovative therapies through precise epigenetic modifications.

Links
Website
Back to HomeBack to Epigenome Editing DealsView Funding Announcement